6 Hours or Less of Sleep a Risk Factor for Aggressive Breast Cancer

Published Online: Tuesday, September 18, 2012
Follow Pharmacy_Times:

Post-menopausal breast cancer patients who sleep 6 hours or less a night are at a higher risk of developing biologically aggressive breast cancers, reported researchers in the August 2012 issue of Breast Cancer Research and Treatment.

The findings are based on an analysis of medical records and survey responses from 412 post-menopausal breast cancer patients treated at University Hospitals Case Medical Center. The participants were recruited at diagnosis and questioned about their sleep patterns over the previous 2 years. The researchers also used an Oncotype DX breast cancer assay—a test that analyzes the expression of a panel of 21 genes in a tumor—to try to predict likelihood of cancer recurrence for each patient.

The researchers found that post-menopausal women who reported 6 hours or less of sleep on average before breast cancer diagnosis had higher Oncotype DX tumor recurrence scores. Despite these findings, there was no correlation found in pre-menopausal women, which the authors attribute to the different underlying mechanisms of pre-menopausal and post-menopausal breast cancers.

“This is the first study to suggest that women who routinely sleep fewer hours may develop more aggressive breast cancers compared with women who sleep longer hours,” said lead author Cheryl Thompson, PhD, assistant professor at Case Western Reserve University School of Medicine.



Related Articles
Community pharmacists play a significant role in helping patients to maintain the health of their skin.
Despite advances in pain management and palliative care, intractable cancer pain remains a significant clinical, social, and financial burden in treating the oncologic population.
AbbVie, Roche, and Genentech are collectively developing the drug to treat relapsed or refractory CLL patients with the 17p deletion genetic mutation.
Teva is voluntarily recalling select lots of intravenous fluorouracil (Adrucil).
$vacMongoViewPlus$
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$